£11.6M
LabGenius raises £11.6m in a Series A extension led by Atomico to scale its drug discovery platform.
The funding round was led by Atomico with participation from Lux Capital, Obvious Ventures, Kindred Capital and Inovia Capital.
L
LabGenius
LabGenius discovers next-generation protein therapeutics using machine learning and automation.
London, UK
£11.6MTotal raised
LabGenius develops machine learning-driven protein engineering platforms to discover next-generation therapeutics. The London-based company uses robotic automation and synthetic biology to improve drug discovery.
Categories
Founders
JF
James Field
Founder and CEO